Sabinsa to showcase clinically-backed ingredient portfolio at SupplySide Connect New Jersey

Published: 25-Mar-2026

The brand highlighted that its GRAS-compliant ingredient portfolio will be ideally placed for brands looking to enter the fast-growing functional beverage market, as well as other delivery forms

Ingredient supplier Sabinsa will be showcasing its portfolio of clinically-backed, category-leading ingredients at SupplySide Connect New Jersey at the Meadowlands Exhibition Centre in Secaucus, NJ, April 14–15, 2026.

The brand will be located at booth #301, where visitors can also read its recently published book Amla: Super-Fruit with Superior Science. Sabinsa describes the book as an "authoritative compendium" that explores the chemistry, biochemistry and biological mechanisms of amla (Phyllanthus emblica) and its role in human health.

"SupplySide Connect is the ideal setting for formulators who want to go beyond commodity [catalogue] browsing and have real conversations about the science behind the ingredients," said Shaheen Majeed, Global CEO & Managing Director, Sabinsa.

Our team will be ready to discuss clinical data, application-specific formulation challenges and how our ingredients can power the next generation of functional products.

The company added that, due to the rapid growth of delivery forms such as functional beverages, its GRAS-compliant ingredient portfolio was ideally placed for brands looking to enter the market. 

Visitors to the booth can sample effervescent powders, ready-to-drink mixes, chewable tablets and functional tablets and capsules, with ingredients such as BioPerine, Curcumin C3 Complex and DigeZyme featured at the show. 

You may also like